Detalhe da pesquisa
1.
NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.
J Neurooncol
; 161(2): 309-316, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36436149
2.
NF2 mutation associated with accelerated time to recurrence for older patients with atypical meningiomas.
Br J Neurosurg
; : 1-7, 2023 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096420
3.
Association of mutations in DNA polymerase epsilon with increased CD8+ cell infiltration and prolonged progression-free survival in patients with meningiomas.
Neurosurg Focus
; 52(2): E7, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35104796
4.
NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.
Cancer Immunol Immunother
; 70(1): 169-176, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661686
5.
Peritumoral edema correlates with mutational burden in meningiomas.
Neuroradiology
; 63(1): 73-80, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32789536
6.
Changes in Nup62 content affect contact-induced differentiation of cultured myoblasts.
Differentiation
; 114: 27-35, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554220
7.
STK11 mutation status is associated with decreased survival in meningiomas.
Neurol Sci
; 41(9): 2585-2589, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253637
8.
Role for NUP62 depletion and PYK2 redistribution in dendritic retraction resulting from chronic stress.
Proc Natl Acad Sci U S A
; 111(45): 16130-5, 2014 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25349423
9.
Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.
Am J Pathol
; 180(1): 375-89, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22074739
10.
ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas.
J Cancer Res Clin Oncol
; 149(8): 5165-5172, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36348021
11.
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
Nat Med
; 29(11): 2825-2834, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37783966
12.
Association between tumor mutations and meningioma recurrence in Grade I/II disease.
Oncoscience
; 9: 70-81, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36514795
13.
SWI/SNF chromatin remodeling complex alterations in meningioma.
J Cancer Res Clin Oncol
; 147(11): 3431-3440, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33715086
14.
Aberrant methylation underlies insulin gene expression in human insulinoma.
Nat Commun
; 11(1): 5210, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33060578
15.
Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas.
Oncotarget
; 10(37): 3506-3517, 2019 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31191822
16.
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
Nat Med
; 30(4): 1211, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242983
17.
Odor detection ability and thallium-201 transport in the olfactory nerve of traumatic olfactory-impaired mice.
Chem Senses
; 33(7): 633-7, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18534997
18.
Colocalization of MCM8 and MCM7 with proteins involved in distinct aspects of DNA replication.
Microsc Res Tech
; 71(4): 288-97, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18072282
19.
Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse.
Mol Cell Biol
; 23(19): 6857-75, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12972605
20.
[Olfactory disturbance screening with the odor stick identification test (OSIT-J) in executive checkups].
Nihon Jibiinkoka Gakkai Kaiho
; 110(8): 586-91, 2007 Aug.
Artigo
em Japonês
| MEDLINE | ID: mdl-17874540